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Abstract 
 
Millions of people suffer from tinnitus, a disorder for which there is currently no effective 
treatment or cure. My dissertation work provides insight into the neural correlates of this pervasive 
hearing disorder and examines how a newly emerging therapy, transcranial magnetic stimulation 
(TMS), affects the central auditory system in the generation of the tinnitus percept. This work has 
a multifold focus of: i) developing and modeling the function of a miniature magnetic coil that can 
be used for TMS in rodents, ii) establishing a reliable mouse model of tinnitus that can be used for 
assessing TMS treatment-induced changes, iii) measuring the behavioral alterations and neural 
changes induced by TMS throughout the auditory system in mice with tinnitus, and iv) to assay 
underling molecular changes in the auditory cortex (AC) related to TMS and tinnitus. Chapter 1 
gives an overview of the current research on tinnitus and TMS. Chapter 2 establishes a reliable 
neural and behavioral assay of verifying tinnitus in a mouse model and provides further evidence 
that the underlying hyperactivity associated with tinnitus is initiated in the brainstem following 
reduced afferent input. The remainder of the dissertation examines the modulation of tinnitus in 
the auditory central nervous system using a miniature TMS coil. Chapter 3 of the dissertation 
details the creation and evaluation of a rodent-sized TMS coil, which could increase the overall 
effectiveness and applicability for human treatment. TMS is currently an FDA approved treatment 
of depression and has been shown to decrease tinnitus perception in human clinical trials, albeit 
with variable results. There have been few published studies of tinnitus modulation by TMS using 
animal models and therefore little is known about the molecular and neural bases of this potential 
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tinnitus treatment. TMS is thought to be therapeutic because the magnetic flux generated from the 
electromagnetic coil induces an electric field in the brain, altering ion flow and subsequently neural 
function, as the excitation and inhibition of cortical networks become synchronized to the magnetic 
pulse. Chapter 4 demonstrates that TMS with our custom-designed miniature rodent coil can 
successfully reduce behavioral evidence of tinnitus in a mouse model, mainly through activating 
inhibitory networks in the AC. It also shows that presynaptic activity is altered in the upper layers 
of the AC responsible for intralaminar processing and sound perception. Finally, chapter 5 
describes an in-depth proteomic analysis of over 3000 proteins from the AC, which shows that 
TMS and noise-induced tinnitus alter the expression of several key proteins and pathways that play 
a critical role in cortical excitatory and inhibitory activation. The results of this work are also 
important because they are the first animal model to demonstrate neural changes during TMS-
treated tinnitus, creating a paradigm that can be used for optimizing parameters to improve clinical 
outcomes in human trials. 
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Chapter 1: Introduction 
 
1.1 Tinnitus Prevalence and Models 
 Chronic tinnitus, or “ringing of the ears,” is an auditory perception not attributable to an 
external source, with prevalence as high as 42.7% in older individuals [1]. As many as 40 million 
people in the United States have reported experiencing tinnitus [2]. It is also the most-reported 
service-related disability for those returning from Middle Eastern conflicts, with over 1.4 million 
veterans receiving military compensation annually for tinnitus [3]. While there are several studies 
that have examined novel methods of tinnitus assessment [4-6], there is currently no objective 
measure of tinnitus [4]. More importantly, there is also no cure for tinnitus, with treatment most 
often using some form of cognitive behavioral therapy, masking devices, hearing aids when 
tinnitus is concomitant with hearing loss, and medication to manage anxiety and other associated 
symptoms [7, 8]. Furthermore, the underlying mechanisms of tinnitus are still not fully understood, 
necessitating the use of animal models to establish differences in neural processing and molecular 
changes.  
 In order to develop and optimize therapeutic interventions, animal models are often 
required. There are two ways to induce tinnitus in animal models, drug-induced and noise-induced. 
Drug-induced tinnitus is often studied through temporary tinnitus induction using quinine, 
salicylate, and other ototoxic drugs [9-13]. The most common of these is high doses of sodium 
salicylate (i.e. aspirin), which reliably induces tinnitus and has been used as a proof of concept for 
many neurological and behavioral measures of tinnitus including those used in this dissertation 
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[14-19]. One of the problems with using salicylate is that it has been shown to cross the blood-
brain barrier [20] and directly affect central neural structures [13, 21-23]. This differs from the 
effects observed using noise-induced tinnitus, where the neural changes occur following decreased 
peripheral input, similar to the etiology of tinnitus in many human sufferers. However, one 
disadvantage of the noise-induced tinnitus animal model is that it only produces tinnitus in 30 – 
86% of animals that are noise exposed, whereas with aspirin all animals reliably develop tinnitus 
[24, 25]. The optimal-noise trauma paradigm will lead to animals developing tinnitus without the 
confounding variable of permanent sensorineural hearing loss. The typical noise trauma exposure 
used in rodents is an 8-16 kHz band of noise played at 110-116 dB SPL for 45-60 minutes [26]. 
Slight modifications of this protocol have been successfully used to induce tinnitus in CBA/CaJ 
mice (86%) [27], C57BL6/J mice [28], and gerbils (78%) [29], all without permanent hearing loss. 
A recent study of 12 combinations of noise and intensity exposures in rats found that behavioral 
evidence of tinnitus was most reliable (50% success rate) after a 30-minute exposure of a 116 dB 
16 kHz octave band noise, which did not induce any measurable hearing loss [26].  
1.2 Underlying Neural Mechanisms of Tinnitus 
 Tinnitus-induced changes in neural activity can be observed throughout the auditory 
system, which is divided into a peripheral portion encompassing the outer ear, inner ear, cochlea, 
and auditory/cochlear nerve, and a central portion with major processing centers that include the 
cochlear nucleus (CN), superior olivary complex, lateral lemniscus, inferior colliculus (IC), medial 
geniculate body, and the AC [30, 31]. The peripheral auditory system is responsible for converting 
sound into neural inputs, while the central portion processes this into fundamental auditory 
dimensions such as spectral, temporal, and binaural sound features and generates the perception 
of sound [31]. Following processing in the brainstem, thalamic information projects to the granular 
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(middle) layers of the AC, typically referred to as layer III/IV, via inputs from the medial 
geniculate body, which then spreads through intralaminar connectivity. This thalamocortical 
network is topographic and largely reciprocal. Though there are other inputs from the thalamus to 
the AC, they are considerably weaker. The supragranular (top) layers are thought to project to 
other cortical areas as well as the infragranular (bottom) layers, which then mostly form 
descending projections to lower nuclei [32-34]. The primary AC has also been shown to be 
tonotopically organized in every species studied [35], with the mouse cortex arranged in a 
logarithmic manner and a recent study indicating that all tonal stimuli over 30 kHz elicit responses 
from the same area [36]. The AC is also organized in a laminar fashion, distinguishing it from 
several subcortical nuclei, with the layers linked vertically through the axons of interneurons [35]. 
In addition, differences in laminar processing suggest each layer of the AC is modulated locally in 
ways that are not fully understood [34]. Cell types in the AC are mostly separated on a laminar 
basis. The superficial layer I contains horizontal cells and terminals from other cells, layers II and 
IV have granule cells designed to receive input from the thalamus, the large pyramidal cells in 
layer V and smaller “external” pyramidal cells in layer III create projections to other layers/nuclei, 
and layer VI contains many cell types [37]. Gamma-aminobutyric acid (GABA) modulating inputs 
on pyramidal cells mainly come from basket cells and multipolar neurons found in the upper layers 
[37]. These GABA accumulating neurons are distributed throughout the AC, and likely project to 
targets within short distances [34]. Studies of the cat primary AC have found that the proportion 
of GABAergic neurons range from > 90% in layer I, 25% in layer IV, to 16 % in layer VI [34, 38]. 
This layer dependent distribution of inhibitory neurons likely plays a key role in the underlying 
mechanisms of tinnitus and how it can be treated.  
 
4 
 Tinnitus was once believed to originate in the cochlea, where deafferentation of pathways 
appear to be the critical triggering factor for tinnitus [39, 40]. However, numerous studies now 
indicate tinnitus is most likely generated from a central origin following deafferentation, due to 
mechanisms including thalamocortical cortical dysrhythmia, central gain changes, homeostatic 
plasticity changes, and increased neural synchrony [41, 42]. Multiple lines of evidence 
demonstrate that cochlear damage does not result in increased driven or spontaneous firing rates 
within the cochlear nerve, and sectioning of this auditory component does not suppress tinnitus 
[42]. Since auditory perception (both phantom and in response to a stimulus) is the result of activity 
in the central auditory system, it is now accepted that tinnitus initiates in central auditory structures. 
This hypothesis is also supported by evidence that many hearing disorders associated with aging, 
ototoxicity, and noise-induced hearing loss lead to a decrease in both spontaneous and stimulus 
induced activity in the cochlear nerve [43], opposite the hyperactivity seen in parts of the central 
auditory system.  
 The central gain model hypothesizes that the excitability of central auditory neurons is 
increased to compensate for decreased sensory inputs [43]. These changes lead to amplification of 
neural noise, and many animal studies have found that tinnitus is associated with changes in the 
central auditory nuclei that include increased spontaneous firing rates, greater neural synchrony, 
and tonotopic map reorganization [12, 44, 45]. These changes in auditory neural processing are 
long lasting, as seen in a study of mice with noise-induced tinnitus, where tinnitus behavior and 
changes in responses specific to the AC were found over a year after noise trauma [46]. This study 
also showed that the increased AC activation correlated with behavioral evidence of tinnitus 
severity and a decrease in GABA sensitivity, which is the ratio of cortical responses to a GABAA 
blockade [46]. In human subjects, PET recordings after treatment with lidocaine, which was found 
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to temporarily abolish tinnitus when administered intravenously, showed that the tinnitus was 
associated with increased metabolic activity in the primary AC, secondary belt regions, and in the 
right frontal paralimbic areas [12, 47]. Functional MRI tests have revealed differences in tinnitus 
groups for sound-evoked blood oxygenation level dependent responses in the AC that researchers 
believe is associated with the tinnitus percept [48, 49]. A key study assessing neural correlates of 
tinnitus in the human brain recorded intracranial low-frequency neural oscillations from the cortex 
of an awake human patient undergoing a surgical procedure to treat intractable epilepsy [50]. A 
residual inhibition paradigm was used to measure short-term modifications in perceived tinnitus 
loudness simultaneous to electrode recordings and found that low frequency (delta) neural 
oscillations decreased with the decrease in perceived loudness, and these changes encompassed all 
of the AC [50]. These delta changes also extended beyond the primary auditory areas, and 
interacted with the alpha, beta, and gamma activity [50]. In addition to these cortical changes, other 
studies have found increased functional responses in non-auditory regions; however, activity in 
the limbic and prefrontal areas could be generated from the associated emotional response to 
tinnitus, and activity in the thalamus may be connected with the conscious perception of the 
phantom sound [48].  
1.3 Neural Plasticity and Tinnitus 
 The neural changes associated with tinnitus are indicative of maladaptive plasticity, or the 
undesired reorganization of the brain in response to variations in sensory input. One view is that 
the central nervous system works to preserve mean neural activity around a set-point level, a 
phenomenon known as homeostatic synaptic plasticity, in the interest of stability using 
compensatory mechanisms [51]. There are two overarching categories of plasticity: rapid 
plasticity, which relies on correlations in neural firing and slow (aka homeostatic) plasticity, which 
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keeps the balance of inhibition and excitation [51, 52]. Rapid plasticity is of the Hebbian type and 
is the process of strengthening synapses when presynaptic activity precedes post-synaptic 
activation, while anti-Hebbian plasticity refers to weakening of synapses when this occurs [39, 
53]. Hebbian plasticity plays a key role in normal auditory functioning in the CN and primary AC 
[39, 54]. These nuclei are fundamental to the perception of tinnitus, as the CN is considered the 
ignition switch of hyperactivity in the auditory pathway and the AC is responsible for generating 
the phantom sound [39, 48, 55]. Evidence that the CN and AC show primarily anti-Hebbian 
plasticity in animals with behavioral evidence of tinnitus, in contrast to the Hebbian plasticity seen 
in normal animals, also highlights their role in the tinnitus percept [39, 56]. Homeostatic plasticity 
also plays an important role in tinnitus, as the reduction in input would result in the strengthening 
of excitatory synapses and the weakening of inhibitory ones [52]. This adaptive plasticity was 
demonstrated in a study of human listeners that underwent two-weeks of continuous earplug use 
or exposure to low-level noise and found that these input modifications significantly altered the 
perceived sensitivity to the loudness of sounds [57]. A study of the timeline of central hyperactivity 
following cochlear ablation in noise-exposed animals found that there was a very late 
centralization of the hyperactivity in the IC, between 6-8 weeks post-exposure [52, 58, 59]. Single 
cell recordings from different areas of the auditory system suggest that the elevated neural activity 
in the AC may also result from homeostatic modifications in the balance of excitation/inhibition 
rather than simply being the result of passive unmasking of excitatory inputs [60, 61]. In fact, when 
GABA inhibition-enhancing drugs, such as Vigabatrin or NO-711, were systemically administered 
to rats with behavioral evidence of tinnitus the treatments reduced the tinnitus measures, while an 
excitation-reducing drug (ketamine) did not [61]. This shows that future tinnitus treatments may 
result from targeting the decrease in cortical inhibition following tinnitus induction.  
7 
 The underlying molecular mechanisms resulting from maladaptive plasticity and changes 
in inhibition/excitation induced by tinnitus in the AC are diverse and complex. Partial 
deafferentation of auditory nerve inputs to the CN following ototrauma results in in decreases in 
inhibitory neurotransmitters including glycine and GABA and changes to their receptors [39, 62, 
63]. These molecular changes are also seen throughout the auditory system, where acoustic trauma 
is shown to be associated with a decrease in cortical GABAergic sensitivity, with a potential 
greater sensitivity to noise trauma in the corticocortical versus thalamocortical projections [46, 64, 
65]. Brain-derived neurotrophic factor (BDNF), a molecule that was implicated in various types 
of CNS plasticity, has also been shown to affect GABAergic inhibition [66, 67]. Furthermore, 
BDNF was downregulated in the AC of rats following noise-induced tinnitus [68]. Another 
molecule that is altered following acoustic trauma is the activity-dependent cytoskeleton protein 
Arg3.1/Arc, which is mobilized through BDNF-mediated activation of the MEK-ERK signaling 
pathway [60, 69]. Arc levels have been shown to decrease in the AC for animals that develop 
tinnitus as compared to those that did not [25, 70]. 
1.4 Underlying Neural Mechanisms of Transcranial Magnetic Stimulation  
 This dissertation focuses on one potential tinnitus treatment called repetitive TMS, which 
has FDA approval for the treatment of depression and has shown efficacy in clinical trials for 
treating human tinnitus patients [71-73]. In addition to many studies where TMS reduced the 
perception of tinnitus, a human electrophysiological study found that TMS treatment reduced the 
magnitude of the auditory steady state response (a non-invasive measure of synchronous evoked 
activity in the AC) on the side ipsilateral to application, which was correlated with a decrease in 
the patient’s rating of tinnitus loudness [72]. TMS is thought to have therapeutic properties because 
the magnetic flux induces an electric field (current) in the brain, thereby affecting ion flow, neural 
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functioning, and spike initiation in neurons [74-76]. Low frequency TMS application (1 or fewer 
pulses/second) has been shown to induce long-term neural depression, thought to be produced 
through changes in Hebbian/spike-time-dependent plasticity [74, 77]. A study of the cellular 
mechanisms of TMS in the rat somatosensory cortex found that changes in inhibitory neural 
networks were due to the recruitment of upper layer interneurons that affected the GABA-mediated 
inhibition of the dendritic portions of layer V pyramidal neurons [78]. This is relevant as AC layer 
IV pyramidal neurons receive inputs from the thalamus [79], and a decrease in activity here 
associated with tinnitus would support efficacy of TMS treatment. 
 Unlike many other medical devices where there has been extensive animal testing, there is 
a lack of animal data related to TMS, especially in the auditory system, which has hindered the 
advancement of this technology. This is primarily due to the challenges in designing rodent-sized 
coils, such as the difficulty in controlling heat dissipation, mechanical stability, and coil placement 
[80]. To solve this, a collaboration with Dr. Jennifer Rodger’s lab in Western Australia was 
initiated to model a suitable miniature TMS coil for rodent testing that has been used successfully 
with mice and guinea pigs [81-84]. This coil produced an electric field well above the minimum 
threshold of 6 V/m that was found in a study of action potentials from neurons in the IC generated 
by stimulating the CN with a micro-magnetic coil with a magnetic field of approximately 10 
milliTesla, which is much smaller than typically used [85, 86]. TMS has been utilized in the 
auditory system of animals in very few studies at the time of publication, only one of which looked 
at treatment of tinnitus. Another of these, from Yang et al., examined hearing thresholds and 
survival rates of neurons in the AC following acoustic trauma, both of which were significantly 
worsened in non-treated rats two weeks following the trauma as compared to TMS treated rats. 
Yang and colleagues also reported that 14 days of TMS treatment on rats with noise-induced 
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permanent hearing loss did not affect hearing thresholds but did attenuate the noise-related loss of 
neurons in the AC [66]. TMS also prevented the immediate trauma-related upregulation in BDNF, 
a molecule that has been shown to affect inhibition [66, 67]. A recent study from our collaborators 
using TMS in guinea pigs resulted in improvement of a behavioral measure of tinnitus, but did not 
affect spontaneous rates in the auditory midbrain [81]. The authors explained that an absence of 
an effect of TMS treatment in the midbrain could be due to the TMS only altering activity in the 
AC, reducing the tinnitus perception without decreasing the hyperactivity that originates in the 
brainstem. This explanation is in line with the thalamic gating hypothesis, which states there is 
always hyperactivity present following hearing loss and the thalamus reduces this increased 
activity in those not experiencing tinnitus [87]. Therefore, it is possible that hyperactive inputs to 
the cortex can be modulated by TMS or other treatments without affecting hyper-excitability 
downstream. TMS in ephrin-A2/A5-/- (knockout) mice with disorganized projections between two 
major visual centers has been shown to improve neural reorganization, promote normal 
connectivity in the superior colliculus, and improve visuomotor tracking when applied for 10 
minutes at one pulse/s over 10 days to a main nucleus in the visual center [83]. This supports the 
theory that magnetic stimulation of cortical structures can restore abnormal neural circuitry and 
alter associated behavioral responses.  
1.5 Development of Tinnitus Assays 
 There are a variety of auditory assays used to assess tinnitus in this dissertation, including 
behavioral and electrophysiological measures, which will be discussed in depth in later chapters. 
Animal models of tinnitus were first used in the 1980s and required training rodents to respond 
specifically to the absence of certain sounds [14, 88-91]. In 2006, Turner and colleagues 
established a behavioral measure of tinnitus based on the acoustic startle response that did not 
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require extensive training [14]. The acoustic startle response measures the movement of an animal 
in response to moderately loud noise, which increases with increases in the startle elicitor intensity. 
The startle response can be inhibited using a lower intensity pre-pulse or a silent gap in noise that 
precedes the startle stimulus, termed pre-pulse inhibition. Turner’s study found that noise-exposed 
rats with confirmed tinnitus using an operant conditioning task also demonstrated reduced gap pre-
pulse inhibition of the acoustic startle (GPIAS), indicating that this was an effective measure of 
tinnitus. Consequently, the GPIAS method been used extensively in many studies since [15, 16, 
27, 29, 92-94]. A later study also used noise pre-pulse inhibition of the acoustic startle (NPIAS), 
essentially the inverse of GPIAS and utilizing the same narrowband noise as the gap carrier 
presented as a short duration pulse prior to the startle elicitor, as a control to test for hearing loss. 
Deficits in NPIAS would suggest that hearing loss or temporal processing dysfunction function as 
the main source of gap detection deficits instead of tinnitus, and it is important that NPIAS values 
remain relativity unchanged after noise exposure [26].   
 The auditory brainstem response (ABR) is an acoustically stimulated evoked potential that 
is a non-invasive measured used to assess hearing and characterize activity from the cochlea, 
auditory nerve, and brainstem. The ABR is elicited using brief signals which generate a waveform 
comprised of 5-7 peaks depending on species, with the different peaks representing activity from 
various nuclei from the auditory nerve (peak 1 in the mouse) to the midbrain (peak 4) [95-97]. The 
ABR is useful because its noninvasive nature allows for repeated measurements over time, and it 
gives a reliable measure of hearing threshold. However, it is a far-field measurement of the 
summation of potentials arising throughout the brainstem and does not provide information about 
the changes occurring in cortical and thalamic regions. In order to assay neural activity underlying 
the generation of tinnitus and the effects of TMS, we used a multichannel array to measure 
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extracellular field potentials and multi-unit (MU) activity from the AC. These included local field 
potentials (LFPs), which measure contributions from any excitable membrane or transmembrane 
current, though synaptic activity is the most important source of current flow [98]. LFPs are the 
low-frequency component (typically filtered at 2-300 Hz) of the acoustically evoked waveform 
and are thought to result mostly from the dendritic processing of synaptic inputs [99]. If LFP 
recordings sites are close enough, typically within 100 µm, the current source density (CSD) can 
be calculated, giving a volume density of the net current. CSD analysis assists in the visualization 
of current flow, as the inward flow of cations to the intracellular space gives rise to a sink, which 
must be balanced elsewhere along the neuron with a current source, or flow of cations to the 
extracellular space [98]. This is relevant to tinnitus studies or others looking at altered 
inhibition/excitation, as the sources represent activity inhibitory currents\passive return current. 
MU activity is a measurement of the brief voltage spikes during action potentials of neurons near 
the electrodes [100], and is used to give measures of spontaneous firing rates, maximum sound-
evoked spike rates, and quantifications of neural tuning and threshold. One thing to note is that 
there is little correlation in MU activity and LFP amplitude [98], so increases in one does not mean 
that similar changes will occur elsewhere.  
1.6 Overview of Dissertation 
 There are 3 major questions that this dissertation hopes to answer surrounding TMS in the 
treatment of tinnitus: 1) How effective will this treatment prove in a study that limits the range of 
variables outside the control of human clinical trials? 2) Are reductions in behavioral assays of 
tinnitus associated with changes in evoked potentials from the auditory brainstem, midbrain, 
and/or cortex? 3) Are there any molecular changes that underlie tinnitus and treatment related 
changes? The dissertation is organized so that each chapter contains a separate study related to at 
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least one of these questions. Following this introduction, Chapter 2 is a published study in PLOS 
ONE on the mechanisms of drug-induced tinnitus, and details the methods used to assess the 
behavioral and brainstem evoked potential correlates of tinnitus in our mouse model. Chapter 3 
was published in Frontiers in Neural Circuits and presents the construction and modeling of the 
rodent-sized TMS coil. Chapter 4 contains the results of the study using this TMS coil in a noise-
induced tinnitus model, where the behavioral responses were assessed in addition to measurements 
of overall neural activity in the brainstem and direct recordings of cortical activity. Chapter 5 
details the measurement of underlying molecular mechanisms in the AC taken from mass 
spectrometry of this tissue. Chapter 6 gives the overall conclusions of my dissertation work.   
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Chapter 2: Alterations In Peripheral and Central Components of the Auditory Brainstem 
Response: A Neural Assay Of Tinnitus 
 
This study1 was undertaken to develop a reliable method for the assessment of tinnitus, and 
to investigate some of the underlying neural mechanisms that occur in the auditory brainstem. 
There were three major findings presented in this paper. The first was that behavioral evidence of 
drug-induced tinnitus correlated with elevations in peak 2 to peak 1 ratios of ABR. These peaks 
represent activity from the auditory nerve and the CN, and therefore this data indicate that despite 
reduced input, there were increases in the evoked responses of the first nuclei responsible for sound 
processing within the brainstem. This finding corroborates other studies that show reduced output 
from the cochlea and tinnitus-induced hyperactivity in the CN. This paper was also one of the first 
to show that tinnitus had behavioral correlations to the selective loss of a subtype of auditory nerve 
fibers which underlie changes in the ABR peak 1 amplitude. Lastly, results also showed that 
deficits in temporal processing were present and could be characterized in the brainstem, measured 
with a gap in noise paradigm, which may provide a useful tool for an objective measure of tinnitus 
in human tinnitus patients. This study served as the catalyst for the development and modification 
of custom software for behavior and ABR analysis, along with the creation of grand average 
waveforms that ensured changes in peak latencies between mice did not affect amplitude 
visualization. The overall conclusions were that ABR peak amplitudes can provide a meaningful 
                                                          
1This article (Lowe, A.S. and Walton, J.P., Alterations in peripheral and central components of the auditory brainstem 
response: a neural assay of tinnitus. PLoS One, 2015. 10(2): p. e0117228.) is published in PLOS ONE and can be 
found in Appendix C. 
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assay of tinnitus, and that central hyperactivity can be measured through noninvasive and 
longitudinal ABR measurements.  
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Chapter 3: Construction and Evaluation of Rodent-Specific Repetitive Transcranial 
Magnetic Simulation Coils 
 
This paper2 details the development of a rodent-sized coil for TMS and characterizes the 
electric and magnetic fields induced around the coil and in the brain tissue. Finite element 
modeling via COMSOL using the dimensions and parameters consistent with brain and skull tissue 
in a rodent demonstrated that TMS could induce an electric field in the brain above the threshold 
of neural activation and reach a depth of 1 mm, encompassing the entire depth of the AC in mice. 
This study also showed that the miniature coil is capable of significantly increasing motor evoked 
potential amplitudes in rats during magnetic stimulation. TMS coils used for the treatment of 
human patients are typically set to a percentage of the power output that evokes movement when 
applied over the motor cortex, and it was important to show that a focal rodent-sized coil can elicit 
these responses. The paper also compared the focality of the custom-designed coil to that of 
commercially available TMS units, which are typically used in rodent studies. We found that the 
custom miniature coil targeted just the cortical layer, similar to human studies, instead of the 
entirety of the brain. Overall, the conclusion reached by this study showed that our custom rodent-
sized coil is capable of altering cortical excitability and can be reliably used to investigate the 
underlying mechanisms of TMS treatment in rodent disease models, which is important for 
refining and understanding treatment options. 
                                                          
2This article (Tang, A.D., Lowe, A.S., et al., Construction and Evaluation of Rodent-Specific rTMS Coils. Frontiers 
in Neural Circuits, 2016. 10.) is published in Frontiers in Neural Circuits and can be found in Appendix D. 
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Chapter 4: Behavioral and Electrophysiological Changes Induced by Transcranial 
Magnetic Stimulation During the Treatment of Tinnitus 
 
TMS in tinnitus patients has shown preliminary success in clinical trials, but the underlying 
mechanisms of this treatment’s benefits are not well understood. This is due to the lack of animal 
studies on how TMS works in the auditory system, especially during treatment of disorders such 
as tinnitus. The goal of the experiments presented in this chapter3 was to establish a rodent model 
of TMS and tinnitus that could be used for assessing how treatment-induced changes in neural 
activity throughout the auditory system interact with evidence of tinnitus perception. As expected, 
TMS treatment did not improve tinnitus-related hyperactivity in the lower auditory brainstem. 
However, the group receiving 15 days of active TMS treatment showed improvements in the 
behavioral indicators of tinnitus and in neural measures including the bandwidth of AC tuning 
curves, evoked firing rates, and spontaneous activity. There were also significant improvements in 
presynaptic activity, as measured by LFPs and CSDs, demonstrating that treatment increased 
measures of inhibitory activation, specifically in the upper layers of the AC. This indicates that 
TMS treatment of tinnitus can be effective at the cortical level, where the tinnitus percept is thought 
to be generated. We found these TMS-induced improvements in behavioral and cortical measures 
of tinnitus occurred despite minimal changes to the hyperactivity measured through evoked 
brainstem responses. This is in agreement with the thalamic gating theory of tinnitus stating that 
                                                          
3Portions of this chapter are in preparation for submission to Nature Neuroscience.   
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hearing loss always induces hyperactivity in the brainstem, which is gated at the level of the 
thalamus in those not experiencing tinnitus, meaning that changes in the AC are what must be 
altered for tinnitus relief. Our results were obtained by measuring changes in behavioral assays of 
hearing and auditory evoked potentials from the brainstem and AC comparing a control group of 
normal adult mice and those with noise-induced tinnitus receiving sham treatment. These markers 
of tinnitus were also evaluated in comparison to a group of mice with noise-induced tinnitus 
following 10-15 days of unilateral TMS treatment. TMS has been shown to activate inhibitory 
networks in the cortex, and the results of this study indicate that TMS treatment likely decreases 
the tinnitus percept through this mechanism. It also provides an effective animal model for 
optimizing TMS parameters, critical for future studies seeking to improve clinical treatment in 
human tinnitus sufferers. 
4.1 Introduction 
Chronic tinnitus is a highly prevalent auditory perception not attributable to an external 
source and affects upwards of 15% of adults [101]. It is now accepted that tinnitus is characterized 
by maladaptive plasticity in central auditory structures, demonstrated by increased spontaneous 
neural activity and synchronization within these nuclei despite reduced peripheral input [43, 55, 
102, 103]. Research has implicated several auditory structures beginning with the cochlea and CN 
[55] in the onset of tinnitus. The central gain theory has been supported in many studies of tinnitus 
and postulates that deafferentation of the cells that transmit information to the brain leads to 
hyperactivity within ascending auditory structures. This happens because the brain is wired to 
maintain neural homeostasis, at a cost of amplifying neural noise following reduced input [43, 
104]. In addition to the changes in neural activity, there may also be functional alterations at 
multiple levels which propagate the spread of abnormal signals in the auditory system [42]. There 
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is an abundance of evidence that AC plays a prominent role in tinnitus and demonstrates 
diminished sensitivity to GABA, a major inhibitory neurotransmitter [46, 64, 65]. There is also 
evidence that the primary AC abnormally amplifies neural activity in response to auditory stimuli 
by way of hyper-responsive intracortical circuits following tinnitus induction [17, 18, 46, 94, 105-
108].  
There is currently no effective cure for tinnitus, though an emerging therapy, TMS, has 
shown some promise for treatment of this disorder. TMS involves the use of transient, high-
intensity magnetic fields applied near the skull and is both painless and noninvasive [109]. It alters 
neural coding because the magnetic flux induces an electric field in the brain, thereby affecting 
ion flow, neural functioning, and spike initiation in neurons [74-76]. TMS has gained FDA 
approval for the treatment of depression and has undergone clinical trials with human subjects for 
the treatment of tinnitus [110]. Preliminary results from different labs indicate success for the 
majority of patients and it has been classified as having possible efficacy in tinnitus treatment [71-
73, 111]. TMS is hypothesized to improve the perceived severity of tinnitus based on findings that 
it can alter cortical activity and various neuroplasticity markers [112-115], therefore diminishing 
the effects of tinnitus-related maladaptive plasticity. This is also congruent with evidence showing 
that down-regulation of cortical GABAA synaptic transmission leads to the cortical hyper-
excitability associated with tinnitus [61, 65]. In fact, a study examining the effects of TMS on AC 
activity in human tinnitus sufferers found that TMS reduced cortical responses to an auditory 
steady-state stimulus, with these decreases correlating with a reduction in the subject’s perception 
of tinnitus loudness [72]. A major hindrance to the advancement of this technology is the lack of 
information on the underlying neural mechanisms. This is because of several challenges, such as 
the difficulty in controlling heat dissipation, mechanical stability, and coil placement when sizing 
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down the coils for use with rodents [80]. Due to these challenges, most animal studies of TMS 
have used the smallest commercially available magnetic coils, which are approximately 80 times 
larger than the surface of the AC [66, 116, 117]. Imaging techniques measuring blood flow 
throughout the brain of rats receiving treatment showed that these coils are not sufficiently focal 
to isolate specific areas of the brain [117].  
The first study to examine TMS and tinnitus in an animal model found that treatment with 
a low intensity magnetic field of approximately 90 milliTesla resulted in improvement in the 
behavioral measure of tinnitus in guinea pigs, but did not affect spontaneous rates in the IC [81]. 
The authors theorized that an absence of an effect in the IC could be due to the TMS only affecting 
the AC, reducing tinnitus perception without modulating descending projections to the midbrain. 
They also cited the thalamic gating hypothesis, which suggests that there is always hyperactivity 
in hearing loss, but the thalamus reduces this increased activity in those not experiencing tinnitus 
for reasons that are not fully understood [87]. Therefore, they reasoned that the TMS could reduce 
tinnitus perception by affecting thalamocortical processing. Yang and colleagues measured the 
effects of TMS on hearing threshold and neuron loss in the AC, both of which were significantly 
worsened in sham-treated rats two weeks following noise trauma [66]. They found that hearing-
impaired rats treated with 14 days of TMS did not have altered hearing thresholds, but TMS did 
attenuate the noise-related loss of neurons in the AC. It also prevented the noise-related 
upregulation in BDNF, a molecule that has been shown to decrease inhibition [66, 67], and 
therefore may play a role in tinnitus. TMS treatment has also been used to alter neural plasticity in 
a genetically modified mouse model that displayed disorganized circuitry in the visual system and 
associated visuomotor deficits [83]. TMS treatment has also been shown to induce neural 
reorganization, which promoted normal connectivity in the superior colliculus and improved 
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visuomotor tracking in treated mice [83]. This supports the hypothesis that low frequency TMS of 
cortical structures can restore abnormal neural circuitry. 
While TMS has shown potential as a treatment for tinnitus, there have been differences in 
effectiveness among human patients. The variability in both the studies and the number of patients 
reporting improvements in positive clinical outcome are likely due to the lack of knowledge about 
the neural mechanisms which occur with this treatment and how best to set various parameters. It 
is important that these mechanisms, along with the efficacy of tinnitus reduction in animal models, 
be further evaluated so that it can be determined if larger clinical trials are worth pursuing. To shed 
light on these questions, this study addressed two major questions surrounding the potential use of 
TMS as a treatment. 1) How effective will this treatment prove in a study that limits the range of 
variables outside the control of human clinical trials? 2) Are the effects on tinnitus shown in 
behavioral indicators concomitant with changes in evoked potentials from the auditory brainstem, 
midbrain, and/or cortex? We used a multidisciplinary approach to assess changes following TMS 
that included behavioral assays, noninvasive longitudinal assays of the brainstem, and direct 
recordings from the AC. Results demonstrated that TMS altered behavioral evidence of tinnitus 
and various aspects of evoked and spontaneous AC activity, without changing hearing threshold 
or lower brainstem responses.   
4.2 Methods 
4.2.1 Subjects 
Subjects were 48 young adult (3-8 months old) CBA/CaJ mice (mixed sex), tested 
longitudinally with baseline, pre-treatment, and post-treatment measurement points. Mice were 
bred in-house from breeders obtained from the Jackson Laboratory (Bar Harbor, ME) at 6 weeks 
of age and housed 3-4 per cage with litter-mates in Sealsafe Plus GM500 cages (36 x 16 x 13 cm) 
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connected to a Aero70 Techniplast Smart Flow system (West Chester, PA). The housing cages 
were maintained at a constant temperature and humidity, using a 12/12-hour light cycle with water 
and food pellets available ad libitum. All procedures were approved by the Institutional Animal 
Care and Use Committee at the University of South Florida (IACUC #M3847). Mice were initially 
divided into 2 groups, those that received noise-exposure and those that did not (the control group, 
n=15). Following noise-exposure, mice that demonstrated behavioral evidence of tinnitus at 6-8 
weeks (18 of the 32 mice) were divided into two groups, an active-treatment TMS group (n=9) 
and a sham-treatment group (n=9), where subjects were placed in the holder under the same 
conditions with the coil turned off.  
4.2.2 Noise Trauma 
To induce tinnitus without the confounding effects of permanent hearing threshold shifts, 
mice were anesthetized and exposed to an 8-16 kHz narrowband noise at 116 dB SPL for 45 
minutes, which resulted in negligible permanent threshold shifts. Slight modifications of this 
protocol have been successfully used to induce tinnitus in CBA/CaJ mice [27], C57B16 mice [14], 
and gerbils [29]. However, many of these studies use unilateral noise trauma to preserve hearing 
in the non-exposed ear. Our rational for using bilateral exposure was that unilateral trauma does 
not replicate the real-world experience where the typical noise trauma that humans encounter 
occurs to both ears. In addition, versions of this model have been used extensively by the Liberman 
lab to induce cochlear synaptopathy [118]. The speaker used in this protocol was calibrated using 
a 1/4” microphone placed at the level of the animal’s pinna which was led to a Larsen Davis 
preamplifier, model 2221 (PCB Piezotronics, Inc., Depew, NY). The animals were exposed to 
noise while under anesthesia induced with ketamine/xylazine (120/10 mg/kg), to ensure that 
movement did not interfere with the sound intensity of the exposure.  
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4.2.3 Transcranial Magnetic Stimulation Treatment 
A miniature TMS coil, scaled down to fit the geometry of the mouse, was created in 
collaboration with investigators studying TMS in the mouse visual system [82, 83], as well as with 
an industrial partner, the Classic Coil Company (Bristol, CT). The custom magnetic coil consists 
of 780 turns of 36-gauge copper wire around an iron core, with a 4-mm outer diameter and a length 
of 10 mm. The coil resulted in a peak magnetic field of 120 milliTesla, measured using a HAL 
1820 linear hall effect sensor with a range of 20 – 160 milliTesla (Micronas, Freiburg, Germany) 
calibrated with standardized magnets (Honeywell Sensing and Productivity Solutions, Golden 
Valley, MN). The coil had a 13 V/m electric field according to simulations, which is above the 10 
V/m shown to activate neurons in the IC [85, 86], cerebellum [119], and AC [120]. This electric 
field occurred parallel to the coil edge, which was positioned over the primary AC based on mouse 
stereotaxic coordinates [36, 121]. The coil was driven by a ± 100 V biphasic (triangular) pulse 
with a 400/400/100 µs rise/fall/rise time. Treatment consisted of 10 minutes of 1/s pulses 
administered over 15 consecutive days, while the mice were awake and mildly restrained. The 
animals were acclimated to the restrainers prior to treatment, given mouse treats following 
handling, and showed no signs of distress during the treatment. The sham treatment consisted of 
placing the mouse in the restrainer for the same duration while under the coil, with the equipment 
turned off.  
4.2.4 Behavioral Assays 
GPIAS was compared to a neural assay of tinnitus and used to determine if an animal 
showed behavioral evidence of this disorder. This method is described in detail in the paper 
included in Chapter 2 [19], and is summarized here for clarity. Each animal’s home cage was 
placed in the testing room for 30 min to allow for acclimation to the surroundings, with assessment 
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of only one sex occurring in a single day. Mice were individually tested in wire mesh cages resting 
on a custom-built platform connected to piezoelectric transducers, located inside one of eight 
identical sound attenuated chambers. Animals were given 5 min for acclimation inside the sound 
chamber before testing. Each animal received three testing sessions, every other day, over the 
course of one week, which included the exposure to broadband noises of varying intensity in 
silence, GPIAS, and NPIAS. The startle-inducing stimuli was a broadband Gaussian noise burst 
(0.5 - 40 kHz), with a duration of 20 ms (1 ms rise/fall time) presented at pseudorandom inter-trial 
intervals between 10 and 20 seconds. GPIAS consisted of a 110-dB startle inducing stimuli 
embedded in a 70-dB narrow band noise (1/3 octave) centered at 10, 16, or 20 kHz presented with 
or without a 50 ms silent gap inserted 100 ms before the startle stimulus. The same GPIAS test 
was repeated with the addition of a tactile (air-puff) stimulus occurring with the 110-dB startle 
elicitor. NPIAS used pre-pulses with the same characteristics as the three narrow-band noises used 
as gap-carriers, presented as 20 ms noise bursts inserted 60 ms before the 110-dB startle stimulus 
to ensure that the mice could hear the gap carrier. Acoustic stimuli were presented through Fostex 
model FT17H speakers (Fostex Company, Tokyo, Japan) located 30 cm directly above the 
transducer platform and controlled with a RZ6 multi-I/O processor from Tucker-Davis 
Technologies (TDT, Alachua, FL) and custom MATLAB software (The MathWorks, Inc., Matick, 
MA). All signals were calibrated prior to testing with a 1/4” microphone placed at the level of the 
animal’s pinna in the sound chamber and led to a Larsen Davis preamplifier, model 2221 (PCB 
Piezotronics, Inc., Depew, NY). Transducer responses to movement (in millivolts) were recorded 
for 125 ms prior and 375 ms following the startle stimulus. Ten trials of every frequency/intensity 
combination were collected during test days. Mice that demonstrated decreases in inhibition to any 
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frequency carrier for the acoustic or tactile GPIAS were considered tinnitus positive, and advanced 
to the treatment phases of the experiment.  
4.2.5 Auditory Brainstem Responses  
The ABR methods are also described in complete detail in the paper included in chapter 2 
[19] and summarized here for clarity. Animals were anesthetized before each ABR with 
ketamine/xylazine (120/10 mg/kg) via intraperitoneal injection, and respiration was monitored 
throughout the experiment to determine when additional supplemental doses were needed. Body 
temperature was kept constant at 37°C using a feedback-controlled heating pad (Physitemp 
TCAT2-LV Controller, Clifton, NJ). Acoustic stimuli were generated using a TDT RZ6 Multi-I/O 
Processor and acquired using BioSigRZ software. Signals were delivered binaurally via a multi-
field (MF1) magnetic speaker (TDT, Alachua, FL) with a total harmonic distortion <= 1% from 1 
kHz to 50 kHz, centered 0° azimuth to the animal at 10 cm from the ear pinnae. Tone bursts were 
presented at frequencies of 6, 12, 16, 20, 24, and 32 kHz (3 ms duration, 1 ms rise/fall time, 
alternating polarity) at a rate of 31 per second, attenuated in 5-10 dB steps from 80 dB SPL to 15 
dB below threshold or 10 dB SPL, whichever was lower. Threshold was determined by visual 
inspection as the lowest intensity level which produced a defined peak in both replicates. All 
signals were calibrated using a Larsen Davis preamplifier, model 2221, with a 1/4” microphone 
and a Larson Davis CAL200 Precision Acoustic Calibrator (PCB Piezotronics, Inc., Depew, NY). 
ABR recordings were acquired using a TDT RA4LI low-impedance digital headstage and RA4PA 
Medusa preamp with the active (noninverting) electrode inserted at the vertex, the reference 
(inverting) electrode below the right ear, and the ground electrode below the left ear. The responses 
were amplified (20x), filtered (100 Hz - 5 kHz), and signals were averaged using BioSig software 
and the System III hardware (TDT) data-acquisition system. Each waveform consisted of 512 
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stimulus presentations that were replicated for each acquisition, and muscle artifacts exceeding 7 
µV were rejected from the averaged response. All recordings took place in a soundproof booth 
lined with echo-attenuating acoustic foam. 
4.2.6 Auditory Cortex Recordings 
The mice underwent surgery to expose the cortex before simultaneously recording LFPs 
and MU activity. These procedures are based on a study of depth-dependent responses in the AC 
[122] with methods similar to previous studies from our lab and others examining responses from 
the IC [123-125]. Animals were anesthetized with ketamine/xylazine (120/10 mg/kg) 
intraperitoneally, and respiration was monitored throughout to determine when additional 
supplemental doses were needed of ketamine only (100 mg/kg). The area over the AC bounded by 
the temporal ridge and the ventral and rostral squamosal was surgically exposed, and the animal 
was secured in a custom stereotaxic frame (Newport-Klinger) in a heated (34 C) chamber lined 
with sound-absorbing foam (Sonex). Recordings were made using a vertically oriented single 
shank silicon acute penetrating 16-channel electrode with an impedance ranging from 1.2 to 2.1 
MΩ (Type-A1x16, 5mm x 50 µm; NeuroNexus Technologies). The electrode was positioned 
stereotaxically over the AC and advanced dorsoventrally by a micro positioner (Newport-Klinger 
PMC 100). The output from the electrode was attached to a low noise (5-6 µV noise floor) pre-
amplifier (RA16), having an operating range of ± 7mV. Neural events were acquired and 
visualized in real-time using the OpenEx software platform (TDT, Inc.) and a custom designed 
MATLAB® graphical interface. Neural recordings from each channel were amplified and sampled 
at 25 kHz over a 1.25 ms time window after the event crossing a voltage discriminator. A spike 
triggering threshold of 3:1 signal to noise ratio was automatically set for all channels. The signals 
were routed to an electrostatic speaker (TDT ES1) with a flat frequency response from 4 to 110 
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kHz, placed at 60° azimuth contralateral to the recording site. Harmonic distortions were measured 
with a Dynamic Signal Analyzer (HP 35665A) and were at least 60 dB below the primary signal. 
The distance between the speaker and the pinna was fixed at 22.5 cm and calibrated using a Larsen 
Davis preamplifier, model 2221, with a 1/4” microphone and a Larson Davis CAL200 Precision 
Acoustic Calibrator. Each penetration typically yielded 8-12 active channels. Recording sessions 
lasted an average of 6-8 hours and if a mouse showed signs of discomfort such as excessive 
movement or respiratory distress, it was removed from the apparatus and testing was halted. 
Sound evoked extracellular single neuron and MU activity was mapped using a 50 ms 
wideband noise search stimulus. After the AC was located, excitatory frequency response areas 
(eFRAs) were acquired using tone bursts generated digitally (Real-time Processor Visual Design 
Studio, TDT) using a System 3 processor and D/A converter (TDT RX6) with 200 kHz sampling 
rate. eFRAs from all active channels were acquired simultaneously using 50 ms (5 ms rise/fall) 
tone burst stimuli presented pseudo-randomly from 0 to 80 dB SPL in 5 dB steps and from 4 to 64 
kHz, for a total of 2125 frequency and intensity combinations. Each eFRA was comprised of each 
tone/intensity combination randomly presented five times each at a rate of 2/s. LFPs were collected 
from 50 presentations of 60, 70, and 80 dB, 50 ms broadband noise bursts, presented pseudo-
randomly. Finally, 5 mins of spontaneous activity in silence was collected. The total recording 
time for each electrode pass depended on the initial search period but took approximately 50-60 
minutes. Most animals had 5-7 recorded passes in a session.  
4.2.7 Data Processing and Statistical Analysis 
4.2.7.1 Behavioral Analysis 
Peak amplitude was defined as the largest positive voltage measurement within 70 ms of 
the first response peak or 150 ms, whichever was shortest. The trial was discarded if the response 
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amplitude in the post-stimulus window was below the mean amplitude plus four standard 
deviations of the pre-stimulus movement-induced voltage from that same trial. This procedure was 
shown in previous studies to be the most effective in eliminating non-startle trials [126]. The 
remaining trials were then averaged for each unique stimulus condition and the gap pre-pulse 
inhibition for each frequency was calculated as a percentage of the response when a gap preceded 
the stimuli to those without. All analysis procedures were built into a custom automated program 
in R [127].  
4.2.7.2 Auditory Brainstem Response Analysis 
For each ABR, peak to trough amplitudes were measured, and latencies computed as the 
time elapsed between the stimulus onset and each analyzed peak. These measurements were 
automated on a waveform-by-waveform basis using custom designed MATLAB software, visually 
verified by individual inspection, and corrected when necessary. Corrections were performed to 
ensure that the chosen peak was the last point before the negative slope, consistent with a 
fundamental method described by Hall [128]. After analysis, the duplicate recordings from each 
signal parameter were averaged for each animal before further analytical analysis. Grand averages 
were generated by cropping each waveform at the onset and offset of P1 and P5, respectively, and 
aligning P1 of each waveform before averaging, with the thickness of the line indicating standard 
error of the mean (SEM). 
4.2.7.3 Neural Recording Analysis 
Spike waveforms were processed in MATLAB® using the TDT OpenDeveloper ActiveX 
controls and passed to AutoClass C v3.3.4, an unsupervised Bayesian classification program that 
seeks a maximum posterior probability classification, developed at the NASA Ames Research 
Center [129, 130]. AutoClass scans the dataset of voltage–time waveforms according to custom 
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specified spike parameters to produce the best-fit classifications of the data, which may include 
distinct single- and multi-unit events, as well as noise. To discriminate the signal from noise in the 
present study, the variance of the background noise was estimated as the quartile range of the first 
five digitization points of the spike waveform, at these are recorded prior to the threshold-crossing 
event. The event data stored includes 30 samples surrounding the event threshold point (as the 
waveforms were sampled at 25 kHz, the sample interval as 40 μs). The variance was calculated 
across all events at each of the 30 points; only points with variance greater than twice the 
background variance were used for sorting (a restriction which limits the number of columns and 
thus computation time but was found not to decrease sorting accuracy). Once classes had been 
determined for each channel of data, they were visualized within a custom MATLAB® pooling 
program which reduced the classes and assigned them to multi-unit, single-unit, or noise classes. 
Event classes which were categorized as noise were subsequently discarded, and units with distinct 
biphasic waveforms and good SNR were classified as single-units. eFRAs were analyzed using a 
custom MATLAB® program which classified tuning using a method similar to that used to classify 
neurons in the primary AC [131] while blinded to the treatment group and animal ID. The 
frequency at which driven activity was responsive at the lowest intensity is classified as the best 
frequency (BF). A custom MATLAB® program was used to calculate the edges of each channel’s 
eFRA, and this was verified via visual inspection to ensure no non-driven activity was included in 
the calculation. The edges of the eFRA were defined as the activity levels that were equal to or 
greater than the background rate and at least 15% of the maximum rate. The bandwidth of the 
eFRA was calculated based on the quality factor (Q), a measure of frequency tuning sharpness. 
These are calculated as the BF divided by the low-frequency edge subtracted from the high-
frequency edge at different intensity levels above threshold [124, 132]. Each eFRA was 
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categorized into regions of BFs based on the behaviorally measured tinnitus percept, which 
averaged 17.2 with a standard deviation of 3.8. Therefore, a tinnitus region of the mean +/- 1 
standard deviation was used. This gave three regions of responses activity consisting of low-BF 
(<13 kHz), tinnitus (mid) BF (13-21 kHz), and high-BF (>21 kHz). From each of these eFRA 
presentations, minimum thresholds (MTs) – the lowest intensity that elicited a response, and 
maximum driven rates were calculated and compared as well.  
The LFPs were filtered (2-300 Hz) from the waveforms elicited by 60, 70, and 80 dB 
broadband noise. Amplitudes were calculated as the lowest (most negative) point in the 100 ms 
that followed the stimulus. LFPs were only used if they were recorded from the same pass which 
elicited a defined eFRA and measurable BF. The CSD was calculated using the Pettersen second 
spatial derivation method of the LFP [99, 133] and a modification of their custom MATLAB 
software. The CSD analysis reveals both current sinks and sources, where sinks reflect net flow of 
positive ions into the neural tissue that corresponds to depolarization, whereas sources reflect the 
net repolarization and inhibition from neighboring neural tissue. The amplitudes of these sources 
and sinks were measured in three layers based on previous studies of the mouse AC – the 
supragranular, granular, and infragranular layers, which are at depths of approximately 0-300, 300-
500, and 500-800 µm, respectively [122, 134]. The average rectified current was also calculated 
for each CSD, this is average of the absolute values at every time point and is useful in quantifying 
the overall activation of cortical tissue [18, 135]. 
4.2.7.4 Statistics and Graphical Representation of Data  
The statistical analysis and graphs were created using GraphPad Prism version 6 
(GraphPad Software, La Jolla, CA) and R [127]. Graphs are presented as bar plots of the mean ± 
SEM and 5-95 percentile box and whiskers plots. A D’Agostino-Pearson omnibus normality test 
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was performed on all data sets, and nonparametric statistics were used in cases where normality 
was not confirmed. Behavioral and ABR studies are able to be performed longitudinally, meaning 
that data include repeated measures, while neural data can only be recorded at one time point, 
necessitating comparison between groups. Therefore, a Freidman test of differences between 
repeated measures with post hoc Wilcoxon matched-pairs signed rank tests corrected for multiple 
comparisons was used for the behavioral and ABR data. A Kruskal-Wallis test with Dunn’s 
multiple comparisons post hoc testing was used to determine differences between the three groups 
for the neural data. All post hoc testing significance is shown in images as *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001. 
4.3 Results 
4.3.1 Behavioral Assays 
Behavioral tests were used to assess tinnitus and ensure that sensory motor gating was not 
impaired following tinnitus induction. Figure 4.1 shows that there were no significant differences 
in the startle response amplitudes to increasing intensity broadband noise bursts between baseline 
and 6-8 weeks following noise trauma (the pre-treatment time point) or during active/sham 
treatment. Startle amplitudes systematically increased for startle eliciting stimuli greater than 75 
dB and asymptote at approximately 105 dB SPL for all groups. A 110-dB broadband noise was 
used as the startle elicitor in GPIAS trials, and we confirmed that the response to the startle elicitor 
was not significantly altered over time to preserve accuracy in tinnitus detection. GPIAS was used 
to determine which mice would remain in the study after noise trauma (i.e., were tinnitus-positive), 
with only those demonstrating a decrease in inhibition to a silent gap when any of the 10, 16, or 
20 kHz 70-dB narrowband noises kept in the study.  
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Figure 4.2 shows the GPIAS for the tinnitus-positive mice, where the left panel illustrates 
inhibition at three time points – baseline, pre-treatment (6-8 weeks following noise trauma and 
immediately prior to active or sham TMS treatment), and during treatment (the last 5 days of 15 
consecutive days of treatment). The right panel of Figure 4.2 shows the mean (SEM) of each 
mouse’s change in inhibition from baseline at the pre-treatment and during treatment time points. 
The active TMS treatment significantly increased GPIAS during treatment in comparison to the 
sham, indicating that TMS increases the salience and/or processing of the silent gap, which was 
reduced in mice with tinnitus. Figure 4.3 shows the GPIAS for the non-exposed control group 
measured at the same time points (6 and 8 weeks) as the TMS groups and indicates that inhibition 
to the gap did not change over time in normal animals. To ensure that hearing loss did not affect 
inhibition by altering perception to the gap carrier instead of the silence, a test using pre-pulses of 
the same intensity and frequency was used (NPIAS), shown in Figure 4.4. Consistent inhibition 
across all three groups for NPIAS indicates that salience of the noise stimulus used in the gap 
carriers was not affected. However, the control group did show increased inhibition over time, 
something that has been seen in other strains of mice [136], and may be due to increased efficacy 
of the circuit underlying this response.  
4.3.2 Auditory Brainstem Responses 
To assess activity in the brainstem and hearing threshold, ABRs were measured prior to 
the exposure (baseline) and for every animal in the noise-exposed group at 1-day post exposure 
and following behavioral testing at 6-8 weeks and during the last 2 days of treatment. In the control 
group, the mice were tested between 6 and 8 weeks following baseline. As expected, there was a 
significant temporary threshold shift 24 hours post exposure, with no differences observed at other 
time points or in the control group, shown in Figure 4.5. While hearing thresholds did not change 
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from baseline, the peak amplitudes were significantly smaller 6-8 weeks post-exposure and during 
treatment. These changes are illustrated in the grand averages shown in Figure 4.6, and the mean 
(SEM) amplitudes in Figure 4.7. Peak 1 (P1) amplitudes, reflecting activity of the cochlea/auditory 
nerve, were significantly reduced, and this reduction was not affected during treatment in either 
group. Despite the reduction in excitatory input to the CN, there were no significant changes in P2 
for the active/sham groups. However, auditory midbrain components showed divergence based on 
treatment, with a significant increase in P4 during treatment for the active group and no changes 
for the sham group. The control group showed slight decreases for all peaks after 6-8 weeks, 
indicating that two months of aging may reduce the overall robustness of the ABR.    
4.3.3 Extracellular Sound Evoked Auditory Cortex Responses 
As a complement to LFP activity, which measures the presynaptic inputs around each 
electrode contact, we also acquired MU activity. Figure 4.8 displays representative eFRAs from 
each group, used to calculate MTs, BF, measures of tuning sharpness, and maximum and 
spontaneous firing rates. Figure 4.9 compares the MTs, which were significantly increased for both 
the sham and active groups in comparison to the control group. Mild hearing loss was expected 
following noise trauma, and TMS was not anticipated to alter this. The right panel in Figure 4.9 
shows the distribution of BFs plotted as a function of group. Both sham and active mice had 
significantly lower BFs when compared to the control mice, where the mean BF range was shifted 
closer to that of the center frequency of the noise-trauma. Figure 4.10 quantifies the broadening of 
tuning curves following noise-induced tinnitus in the sham group, which was not seen in the active 
treatment group. These Q-values are shown at 10, 30, and 50 dB above threshold, and at all 
intensities the active group had significantly higher Q values, meaning sharper tuning. 
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We also measured the maximum sound evoked firing rate from the BF region of the tone-
evoked eFRA, and the spontaneous activity that occurred during silence. Figure 4.11 shows the 
maximum driven firing rates for the evoked AC responses and indicates that the sham-treated 
group had significantly higher sound evoked firing rates than the controls for units with BFs in the 
tinnitus region. The active treatment group showed significantly lower firing rates compared to the 
sham group for these units, as well as those in the lower frequencies. High-frequency units showed 
a divergence from this, where both the noise-exposed active/sham groups had lower firing rates 
than the controls. Figure 4.12 shows the spontaneous activity measured as spikes per repetition in 
the 1000 ms of silence preceding the tone, grouped as a function of each unit’s BF. These followed 
a similar pattern to the evoked firing rates, with the units within the tinnitus region showing 
increases for the sham-treated group in comparison to both the control and active units. The inset 
shows the responses only from pyramidal cell layer IV (thalamic input), which showed the same 
significant pattern of increased rates for the sham group in comparison to the control and active-
treated groups. 
4.3.4 Local Field Potentials in the Auditory Cortex 
LFPs were derived from sites with well-defined eFRAs in a majority of the 16 channels, 
for a total of 26 sites in control, 23 in sham, and 20 in TMS treated mice. The left panel of Figure 
4.13 shows LFP waveforms and heat maps for the units in the low- and tinnitus-frequency regions. 
The decrease in LFP activity is evident for the sham group in comparison to the control and active 
groups for the responses originating in the tinnitus (mid-frequency) region. The first negative peak, 
or LFP amplitude, is shown in Figure 4.14 for the low-frequency region, which demonstrated no 
difference between groups for any intensity. However, there was a significant effect of group for 
the tinnitus-region amplitudes, shown in Figure 4.15. Here, the sham group demonstrated a 
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reduction in overall amplitude by 38% at 80 dB compared to the control group, which were 
restored and no longer different from control in the active-treated group. There were not enough 
high-frequency LFPs to determine significance for the active and sham groups, due to the lower 
number of defined eFRAs in this region. Figure 4.16 shows the CSDs derived from the LFPs in 
the low and tinnitus frequency regions, and the waveforms taken from the supragranular, granular, 
and infragranular layers. Red represents sinks, or the inward flow of cations to the intracellular 
space, while the blue represents sources, or the flow of cations to the extracellular space. The 
current sinks are thought to make up the net excitatory synaptic current or excitatory drive, to the 
post-synaptic target. These sink and source amplitudes are shown in Figure 4.17, and demonstrate 
a significant difference for 80 dB evoked CSDs in the supragranular (top) layers of the AC. Here, 
the measured sink for the sham CSDs was lower than that of the control and active groups. 
 Finally, the average rectified current, a measure of power for the overall CSD was 
calculated for the responses to a 70 dB noise stimulus in the tinnitus frequency region and are 
shown in Figure 4.18. While there was a large difference in the average waveform, and a trend 
towards lower sink amplitudes in the sham group, neither peak showed a significant effect of 
group. This was also the case for CSDs calculated in response to the 60 and 80 dB stimuli. This 
may be due to the average rectified current representing activity from the entirety of the AC, while 
noise and treatment-induced changes occurred mostly in the upper and middle layers. While useful 
for visualizing the overall activation of the cortical tissue, this measure is not as sensitive as the 
layer specific waveforms. 
4.4 Discussion 
Behavioral evidence of tinnitus in animal models relies on operant conditioning or 
behavioral assays to determine the animal’s salience to silence versus various sounds. Decreases 
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in pre-pulse inhibition to silent gaps embedded in background noise have been used in many labs 
to identify animals exposed to noise and subsequently showing signs of tinnitus [15, 16, 27, 29, 
92-94]. Our study showed similar results, with 18 of the 32 mice demonstrating behavioral 
evidence of tinnitus through reduced salience of a silent gap. We also found no significant changes 
in other behavioral assays, indicating that startle response intensity function and salience of the 
70-dB narrowband noise pre-pulses were not affected following tinnitus induction. The major 
finding of the behavioral part of the study was that active TMS treatment reduced tinnitus, while 
sham treatment did not. Our results align with the only other study to examine TMS and tinnitus 
in animals to date, which used a similar coil with TMS treatment consisting of 1/s pulses for 10 
min/day over 14 days in guinea pigs. The authors also reported that TMS treatment improved 
inhibition by 35% from a tinnitus-induced 55% decrease in the GPIAS paradigm [81]. The goal in 
this study was to induce tinnitus in mice without the confounding effects of considerable 
permanent hearing loss. This was accomplished, as indicated by no significant changes in ABR 
thresholds from baseline 6-8 weeks post-exposure. Active TMS treatment had no effect on hearing 
threshold, as found in an earlier study that utilized noise trauma designed to induce permanent 
hearing loss [66]. We also found no TMS-induced changes to ABR peak amplitudes (P1 and P2) 
that originate in the auditory nerve and CN. However, there was an increase in evoked ABR 
activity from the midbrain following active treatment that was not seen in the sham group. One 
theory for this unexpected change is that descending corticofugal projections from the AC have 
been shown to play a role in shaping response properties in the auditory midbrain and can be 
excitatory or inhibitory in their effects on these neurons [81]. This includes several studies that 
have demonstrated that focal electric stimulation of the AC affects frequency tuning curves, the 
magnitude of sound evoked activity, and other sound processing measures in the IC through the 
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sharpening or broadening of eFRAs and alteration sensitivity cues for the localization of sound in 
space [137-141]. 
Neural recordings from the AC of the sham group indicated that our noise-exposure 
paradigm induced similar changes as other studies of noise-induced tinnitus. Previous research has 
shown noise-induced tinnitus can cause reorganization of cortical tonotopic maps and increased 
spontaneous activity [142, 143], abnormally large cortical evoked responses to sound stimuli in 
regions associated with tinnitus [144, 145], and eFRA expansion [146-149]. These alterations in 
neural coding are likely due to disruption in the excitatory-inhibitory synaptic balance of neurons 
following acoustic trauma, where selective increases and decreases in inhibition have been 
observed in distinct cortical regions [150]. TMS has been shown to affect GABA-mediated 
inhibition of the dendritic portions of pyramidal neurons that carry information from the thalamus 
[78], and therefore would be expected to alter these signs of maladaptive plasticity. Indeed, the 
active TMS treatment group showed improvements in many of these tinnitus-related changes, 
demonstrated by sharper tuning in the eFRA and spontaneous and sound evoked firing rates that 
were maintained at or below the control group firing rates observed in the tinnitus region.  
Conversely, there was a decrease in LFP amplitude for the sham-treated tinnitus group in 
comparison to the control group, similar to other studies showing decreases in LFPs following 
noise-induced tinnitus [108, 151]. This includes a study using rats, where Laundrie and Sun found 
that noise-exposure (which resulted in a moderate permanent hearing loss and behavioral evidence 
of tinnitus) increased tone-evoked LFPs recorded chronically from AC implanted electrodes only 
at 4 hours post-exposure. One day post-exposure, the magnitude of the LFPs recovered, and at 4 
weeks LFPs were reduced compared to baseline [151]. It is hard to interpret LFP amplitudes in the 
context of inhibition/excitation balance because dendritic excitation and somatic inhibition result 
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in the same direction of current flow; however, it is known that strong dendritic inhibition can 
enhance the magnitude of the LFP while preventing the occurrence of action potentials in 
pyramidal cells [98]. This may explain why LFP amplitudes were decreased in the sham-treated 
tinnitus group despite increases in evoked and spontaneous firing rates, and that these measures 
were returned to normal following TMS treatment, which is known to activate dendritic inhibition 
[78]. A recent study demonstrated that LFPs primarily reflect inhibitory neuron activity in the 
human and monkey cortex [152], which also supports the contrasting LFP and MU activity results 
for the sham-treated tinnitus group. Lastly, the differences in the two measures may be due to the 
fact that the LFPs were taken from responses to broadband noise bursts, in contrast to the MU 
activity, which was derived from tone bursts evoked waveforms. 
This study also found that the mean eFRA BF was significantly reduced in sham-treated 
tinnitus mice and was not restored with TMS treatment. Though statistically significant, the mean 
difference was approximately 2 kHz, which is relatively small given the five octave hearing range 
of the mouse and much lower than other studies, all of which used animal models where significant 
hearing loss was present [42, 44, 61, 149, 153]. Importantly, a study of cats with only small shifts 
in hearing threshold found changes in cortical inhibition without any indication of tonotopic 
reorganization, or the distribution of BFs [154]. Recent work has found that tonotopic 
reorganization was not present in human patients with tinnitus and no hearing loss [155-157] and 
it is now thought that the distortion of cortical tonotopic maps may reflect deafferentation but is 
not directly related to tinnitus [158]. Another possible explanation is that the longer recording 
times used in this AC experiment only allowed for 5-8 passes per animal and recording sites may 
not have covered the entirety of the cortex for each mouse. The goal of this study was to collect 
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spontaneous activity and LFP responses, and this experiment did not focus on mapping the entirety 
of the primary AC. 
A key question surrounding TMS is how the magnetic field activates neural tissue. A recent 
study from the Tateno lab found that magnetic stimulation using a sub-millimeter-sized coil to 
stimulate the mouse AC in vivo induced LFP/CSD responses reaching layer 6, with spatiotemporal 
profiles similar to those that were acoustically driven, suggesting they activate the same cortical 
pathways [120]. The spike waveforms induced by the magnetic stimulation were also very similar 
to those that were acoustically activated, and indicated that magnetically-induced responses were 
spread across different layers of the AC [120]. Engineer and colleagues used vagus nerve 
stimulation and tone pairing to alter plasticity in a rodent tinnitus model and found that there was 
a significant correlation between impairments in neural correlates of gap detection and increases 
in AC eFRA bandwidth (Q-values) and evoked firing rates. The underlying mechanism behind 
this therapy was shown to be the release of a brief burst of neuromodulators [159], similar to the 
what happens with each TMS pulse [160]. The vagus nerve stimulation treatment reduced 
behavioral evidence of tinnitus and returned eFRA Q-values and evoked firing rates in the AC to 
levels seen in the control group [161]. This indicates that the increase in Q-values and the reduction 
in evoked and spontaneous firing rates induced by the active TMS treatment may be the underlying 
factor in the reduced behavioral evidence of tinnitus. These effects are due to alterations in cortical 
inhibition, and therefore our study provides further evidence that this will play a key role in the 
treatment of tinnitus. It also indicates that TMS may prove effective as a treatment because it 
activates the same circuitry used in auditory processing.  
This study used unilateral TMS treatment, similar to previous studies in animals and 
humans [81, 110, 162, 163], and found a reduction in behavioral evidence of tinnitus that utilizes 
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sounds presented bilaterally. While recordings from the AC were only taken from the treated (left) 
side and the experimental setup did not allow for subsequent or simultaneous recordings from the 
contralateral side, a major question remains about how activity there may have been affected. One 
study in humans found that tinnitus was mainly generated in the left AC, leading to the hypothesis 
that treatment here would most effective for tinnitus [162, 164]. A study of five days of unilateral 
1-Hz TMS over the temporal cortex in healthy human subjects found that TMS induced cortico-
cortical modulation, with widespread changes due to long-range neural connections measured 
through positron emission tomography [165]. Future experiments that record from the AC 
contralateral to treatment would provide important insight into the role that cortical binding and 
long-range neural connections play in tinnitus.  
Overall, this study succeeded in developing a mouse model of tinnitus that showed TMS-
induced alterations in cortical responses and improvements in behavioral gap detection. This 
animal model can be used to optimize parameters of TMS such as duration of treatment, efficacy 
of unilateral vs bilateral treatment, and location of coil placement. It also indicates that treatments 
that improve eFRA tuning and firing rates may prove to be effective in eliminating the perception 
of tinnitus. 
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Figure 4.1 Acoustic startle responses to broadband noise. Startle response amplitudes to 
increasing intensity noise bursts are shown for the active-treated (top panel), sham-treated (middle 
panel), and control (bottom panel) groups. There were no significant differences in amplitudes 
between baseline, pre-treatment (6-8 weeks post-acoustic trauma), and during treatment in either 
the active [χ2(2)=6.3, p=0.052] or sham [χ2(2)=1.0, p=0.740] tinnitus groups, similar to 
measurements taken at different time points in the control group [χ2(2)=0.3, p=0.956].  
 
 
 
 
 
 
 
 
 
41 
 
Figure 4.2 Gap pre-pulse inhibition of the acoustic startle response for the tinnitus groups. 
The inhibition for the specific narrowband noise center frequency (10, 16, or 20 kHz) indicating 
tinnitus pitch for each mouse is compared between conditions for the active-treated and sham-
treated tinnitus groups (left panel), and as a difference from baseline (right panel). There was a 
significant overall effect of the treatment point for both active [χ2(2)=10.9, p=0.003] and sham 
[χ2(2)=6.2, p=0.048] groups, with post hoc testing indicating that while pre-treatment inhibition 
was significantly lowered for both groups (i.e. behavioral evidence of tinnitus), only the active 
group demonstrated recovery during treatment. This is also shown in the right panel, where the 
changes from baseline were significantly different during treatment from the pre-treatment only 
for the active group (W=39, p=0.0195).  
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Figure 4.3 Gap pre-pulse inhibition of the acoustic startle response for the control group. 
The averaged inhibition for all tested narrowband noise center frequencies (10, 16, & 20 kHz) is 
compared between time points (left panel) and as a difference from baseline (right panel). There 
was no significant change in inhibition over time [χ2(2)=1.6, p=0.449]. 
 
 
Figure 4.4 Noise pre-pulse inhibition of the acoustic startle response. Inhibition to a pre-pulse 
of the same narrowband noise center frequency (10, 16, or 20 kHz) as the gap-carrier used in 
Figures 4.2 and 4.3 for each animal is compared between conditions for the active-treated, sham-
treated and control groups (where the inhibition as an average of responses to all frequencies is 
shown). The control group showed a significant difference over time [χ2(2)=12.1, p=0.002], 
indicating that inhibition was improved in later sessions. There was no effect for the active 
[χ2(2)=0.9, p=0.685] or sham [χ2(2)=3.6, p=0.187] groups.  
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Figure 4.5 ABR thresholds at the tinnitus frequency. There was an overall effect of condition 
(time from exposure) for the active [χ2(3)=15.4, p=0.002] and sham [χ2(3)=13.9, p=0.003] groups, 
with post hoc testing indicating significance for only the baseline vs 1-day post-exposure. There 
was no difference between time points for the controls (W=3, p=0.750).  
 
 
 
Figure 4.6 ABR grand averages at the tinnitus frequency. Waveforms were aligned at P1, with 
thickness representing standard error of the mean. Grand averages illustrate the decreases in P1 
amplitude for the active and sham groups that does not change during treatment. It also shows that 
treatment did not affect P2 for either treatment group, but P4 was increased at this time point for 
the active group only.  
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Figure 4.7 ABR peak amplitudes at the tinnitus frequency. There was an overall effect of 
treatment point for P1 in both the active [χ2(2)=11.6, p=0.001] and sham [χ2(2)=14.9, p<0.0001] 
groups and for P4 in the active group [χ2(2)=14.0, p=0.002]. All groups showed decreases from 
baseline for both pre- and during treatment conditions. The control group displayed decreases over 
time for P1 (W=-28, p=0.016), P2 (W=-28, p=0.016), and P4 (W=-26, p=0.031).  
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Figure 4.8 Representative eFRAs from the control, sham, and active groups. eFRAs are 
plotted with frequency on the ordinate and intensity on the abscissa, with color indicating the 
strength of response. Darker red indicates higher spiking activity while blue indicates lower 
activity. Q-values are labeled at 10, 30, and 50 dB above threshold. 
 
 
 
Figure 4.9 Minimum thresholds and best frequencies taken from AC eFRAs. Minimum 
thresholds derived from the eFRAs (left panel) showed an overall significant effect of group 
[χ2(2)=73.2, p<0.0001], with both the sham group (n=370 units) and active group (n=338 units) 
showing significant increases from the control group (n=359 units). The right panel shows that 
there was also an overall effect of group for BFs [χ2(2)=52.3, p<0.001], with the sham and active 
groups showing lower median frequencies than the control.  
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Figure 4.10 Q-values taken from AC tinnitus frequency eFRAs at 10, 30, and 50 dB above 
threshold. Q-values represent a measure of eFRA tuning curve sharpness, with higher Q-values 
indicating narrow bandwidths and lower values indicating broader or more diffuse eFRAs. There 
was an overall effect of group at Q10 dB [χ2(2)=47.6, p<0.0001], Q30 dB [χ2(2)=15.3, p=0.005], 
and Q50 dB [χ2(2)=8.7, p=0.013]. Post hoc testing indicated that the active group (n=102 units) 
had sharper tuning at all intensities in comparison to the sham group (n=101 units), which was 
significantly broader than the control group (n=160 units) for Q10. 
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Figure 4.11 Maximum firing rates for evoked AC responses. There was an overall effect of 
treatment group for low-frequency (<13 kHz, n=847) [χ2(2)=56.9, p<0.0001], tinnitus frequency 
(13-21 kHz, n=398) [χ2(2)=70.0, p<0.0001] and high-frequency units (> 21 kHz, n=77) 
[χ2(2)=13.1, p=0.001] eFRA maximum firing rates. Post hoc testing showed that the sham group 
had elevated driven rates only in the tinnitus frequency range, while the active treatment group 
had lower firing rates for both the low and tinnitus-frequency regions. For high frequency units, 
both the sham and active groups had lower driven maximum firing rates than the control group.  
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Figure 4.12 Spontaneous firing rates in the AC. There was an overall effect of treatment group 
for low-frequency (<13 kHz, n=847) [χ2(2)=53.9, p<0.0001] and tinnitus-frequency (13-21 kHz, 
n=398) [χ2(2)=31.3, p<0.0001] regions, but not for the high-frequency region (>21 kHz, n=77) 
[χ2(2)=3.3, p=0.190] spontaneous firing rates. Post hoc testing showed that the sham group had 
elevated responses compared to the control group only in the tinnitus frequency range, while the 
active treatment had lower spontaneous rates that sham units for both low and tinnitus frequencies. 
The inset shows layer IV (thalamic input) responses for the tinnitus frequencies, where there was 
an overall significant effect of group [χ2(2)=7.1, p=0.029]. 
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Figure 4.13 Local field potential waveforms and heat maps for the low and tinnitus frequency 
regions. The grand averaged waveforms for the control, sham, and active LFPs to 70 dB broadband 
noise in the low (top panel) and tinnitus (bottom panel) frequency region are shown on the left. 
The spatial organization of the electrodes along the vertical shank allowed for complete sampling 
of the entire dorsal-ventral extent of AC. The heat maps (right panels) show topographic changes 
in LFPs as a function of time, where the darker colors signify greater negative or positive 
amplitudes. Channel 16 is the dorsal channel and channel 1 is the most ventral. These illustrate the 
reduced amplitudes in the upper layers for the sham responses compared to the active and control 
amplitudes that occurred only in the tinnitus region.  
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Figure 4.14 Local field potential amplitudes for the low-frequency region. The first negative 
peak amplitude is shown by from ventral to dorsal positions (channels 1-16). There was no 
significant effect of group for responses to 60 dB [χ2(2)=0.56, p=0.758], 70 dB [χ2(2)=0.77, 
p=0.680], or 80 dB [χ2(2)=0.525 p=0.881] broadband noise bursts. 
 
 
Figure 4.15 Local field potential amplitudes for the tinnitus frequency region. The LFP 
amplitudes in the tinnitus frequency region did show a significant effect of group for responses to 
60 dB [χ2(2)=7.8, p=0.021], 70 dB [χ2(2)=9.2, p=0.010], or 80 dB [χ2(2)=8.1 p=0.017] broadband 
noise bursts. Post hoc testing indicated that the combined sham and control amplitudes were 
significantly different.  
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Figure 4.16 Current source densities and corresponding waveforms at the supragranular, 
granular, and infragranular layers. CSDs were calculated over the 125 ms following the noise 
stimulus recorded from AC depths of 100-900 µm. The top panel shows the CSDs in the low 
frequency regions derived from the eFRA BFs, while the bottom is for the tinnitus frequency 
region. The waveforms show the grand averages for the three layers separated by the dotted lines. 
The largest amplitudes for the low and tinnitus frequency regions were 2 and 5 mA/mm2, 
respectively. 
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Figure 4.17 Sink and source amplitudes from AC current source densities. The sources (top 
panels) and sinks (bottom panels) are shown for CSD analysis from the LFP 70 dB (left) and 80 
dB (right) responses. Significance was found only for the supragranular layer sink at 80 dB 
[χ2(2)=6.0, p=0.049], though the trend toward reduced values for the sham group was apparent for 
both sinks and sources at both intensities in the supragranular layer.  
 
 
Figure 4.18 Peak amplitudes from the average rectified current of the CSD for the 70 dB 
tinnitus frequency responses. The left panel shows the amplitudes from the first two positive 
peaks of the average rectified current, with the mean waveforms shown in the right panel. While 
there were no overall significant effects of group for the first peak [χ2(2)=2.4, p=0.306] or second 
peak [χ2(2)=1.7, p=0.435], there was a trend towards a decrease in the sham group compared to 
the control and active groups.  
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Chapter 5: Protein Expression in the Auditory Cortex of an Animal Model of Tinnitus 
Following Treatment with Transcranial Magnetic Stimulation  
 
Confirming the underlying mechanisms involved in the positive results incurred by TMS 
in the treatment of tinnitus necessitates an examination of the changes in protein expression in the 
treated AC. This study used mass spectrometry to assay these AC proteins and found many were 
differentially expressed between the control mice and the tinnitus groups. There were also 
significant differences for 89 proteins between the active and sham-treated groups. These included 
receptors associated with inhibitory networks and the differentiation of synapses. There were also 
two major pathways significantly activated in comparison to controls for the sham-treated group 
but not the active TMS group – synaptic long-term potentiation and calcium signaling, which are 
associated with the underlying cortical hyperactivity found in tinnitus models. These results 
provide further evidence that the treatment of tinnitus may be related to both presynaptic changes 
such as calcium signaling and alterations in long-term plasticity.  
5.1 Introduction 
Damage caused by acoustic trauma alters numerous pathways in the central auditory 
system, making the determination of neurotransmitter levels vital for accurate analysis of brain 
function following trauma. One way to analyze multiple proteins from the same tissue sample is 
using proteomics. Proteomics is the large-scale study of proteins with the aim of providing detailed 
descriptions of the structure, function, and control of biological systems. One of the most widely 
used assays for proteomic studies is mass spectrometry, due to its high precision and unbiased 
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information on the protein identity and sample quantity [166, 167]. A mass spectrometer measures 
the mass-to-charge ratio of charged ions under vacuum and is made up of an ionization source and 
a mass analyzer [168]. Data analysis using mass spectrometer based proteomics is more 
challenging than for other high-throughput technologies such as microarrays, which remains the 
principal bottleneck in proteomics [168, 169]. This is because the ionized metabolites must be 
identified by comparing the spectra, in-source fragments, and ion features of each peak in the total 
ionic current of the experimental samples with those from known reference standards or those 
available in libraries [169-171]. However, there have been major technological developments and 
advances in analysis software over the last few years, allowing for a very high degree of sensitivity 
in resolving protein composition [172] and making mass spectrometry a useful tool for determining 
the underlying metabolic changes from specific tissue in neurological disorders such as tinnitus.  
Mass spectrometry has been used to analyze changes throughout the brain in various 
studies on the effects of acoustic trauma or blast injury, though to date none have examined 
changes following behavioral evidence of tinnitus. Zhu et. al. developed a way of utilizing mass 
spectrometry to determine the relative abundance of GABA, dopamine, epinephrine, 
norepinepherine, glutamate, and serotonin in one sample [173]. This method was later used by He 
and colleagues while profiling 12 different brain regions using a gas chromatography/mass 
spectrometry-based metabolomics platform, to analyze the change in brain metabolites between 
normal rats and acoustically-traumatized rats 6 months after a 1-hour exposure to a 16 kHz 110-
db SPL pure tone. When all brain regions were analyzed together in that study, they found no 
differences between the sham and trauma groups. However, when looking at separate nuclei from 
the central auditory system, they found 17 molecules that showed distinct differences between 
control and acoustic trauma groups. Within the AC, the only molecule that was significantly up-
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regulated post-trauma was GABA, while other neural regions each showed four unique molecular 
modulations [170]. The up-regulation in GABA observed by He et. al. is consistent with another 
study of the long-term effects of acoustic trauma on amino acid levels, which also reported 
increases in IC GABA levels using high-performance liquid chromatography following a 4-hour 
exposure to a 10 kHz tone at 127 dB SPL [174].  
Levels of aspartate and taurine throughout the auditory system, which have indirect roles 
in excitatory and inhibitory neurotransmission respectively, were also significantly altered in 
animals receiving the 10 kHz, 127 dB exposure [174]. Another study using high resolution point-
resolved proton magnetic resonance spectroscopy found that GABA and glutamic acid levels in 
the AC of rats with noise-induced tinnitus increased following trauma [175], possibly reflecting 
changes in the inhibitory-excitatory equilibrium. Glutamate decarboxylase 1 and 2 (GAD 1/ 
GAD2, also known as GAD65/GAD67) function as GABA synthetic enzymes and in prior studies 
has been accurately measured in the auditory system [176]. Reductions in these proteins may be 
linked to decreases in both metabolic and pre-synaptic GABA levels, and they have been shown 
to decrease in the AC with aging [177]. GAD67 proteins have also been shown to be expressed 
only in GABAergic neurons [177, 178]. BDNF is produced by the pyramidal neurons, and the its 
receptor, BDNF/NT-3 growth factors receptor (Ntrk2, also known as TrkB), is present on both 
these and interneurons [179]. Increases in BDNF have been shown to decrease inhibition [66, 67], 
and therefore this neurotransmitter likely plays a role in generating the tinnitus perception in the 
AC. In the hippocampus, BDNF was shown to mediate neural activity through its receptor, TrkB 
[67]. BDNF-TrkB signaling has also been shown to increase in rat brains following five days of 
TMS over the motor cortex [180]. Another systemic change associated with tinnitus is long-term 
potentiation, which is thought to occur because prolonged synchronous firing leads to sound 
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evoked synaptic modifications [181]. This was demonstrated with the measurement of tinnitus-
related synchronous firing in the cat primary AC [147]. This is related to calcium signaling, as 
Ca2+-dependent second messenger cascades can induce synaptic modifications via long-term 
potentiation or depression [182].  
5.2 Methods  
The induction of tinnitus and TMS treatment is described in detail in chapter 4 and 
summarized here for clarity. Mice were divided into three groups – control, active-treated TMS, 
and sham-treated TMS. The control group received no noise trauma or treatment and underwent 
the same testing procedures as the other two groups. The active and sham groups were exposed to 
45 minutes of 116 dB, 8-16 kHz narrow-band noise under anesthesia with ketamine/xylazine. 
Following behavioral confirmation of tinnitus 6-8 weeks post-exposure, they received 15 
continuous days of either active or sham TMS treatment for 10 min/day. The active treatment 
consisted of a 120 milliTesla pulses at a rate of 1/s, applied over the left AC while the mouse was 
in a restrainer. The sham treatment was placed in the restrainer for the same duration with the coil 
switched off.  
Following recordings from the AC on the last day of treatment, the mice were euthanized 
with a lethal dose of Euthasol (Virbac, Ft. Worth, TX). All procedures were carried out according 
to IACUC protocol #M3847. The brain was then dissected, with individual auditory nuclei 
removed and flash frozen at -80°C. The left (treated) AC from four animals in each group was 
lysed similarly to a protocol described in a paper using the same proteomics core equipment and 
procedures [183]. First, the tissue was washed with SDS in 100 mM Tris-HCL, pH 7.6 and 
dithiothreitol at 95°C for 5 min. Following sonication and clearance of lysate via 10 minutes of 
20,000g micro-centrifugation, protein concentration was determined via 660 nM protein assay for 
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equal loading, meaning that the same amount of protein was loaded for each sample. Proteins were 
digested overnight using a 1:100 ratio of mass spectrometry grade TPCK-treated trypsin. Samples 
were then concentrated under vacuum and re-suspended in 0.1% formic acid. Mass spectrometry 
analysis was performed on each sample in triplicate using a hybrid quadrupole-Orbitrap instrument 
(Q Exactive Plus, Thermo). The spectrometric data was analyzed on the MaxQuant suite and 
spectra searched against the Uniprot reference database. Identifications were filtered employing 
reversed sequences with a false discovery rate of 1% for peptides. Data was then analyzed using 
Perseus software and methodology developed by the Max Planck Institute of Biochemistry [171]. 
Protein expression was analyzed only if that protein was observed in at least two of the three 
samples. Values obtained from label-free quantitation of the relative expression of the protein were 
normalized using a log2 transformation. A Welch’s corrected t-test was performed to determine 
significance between groups. A z-score was then calculated as the t test difference of individual 
proteins subtracted from the median t test difference divided by the standard deviation of the 
overall t test difference, and a z-score cutoff value of one was used to correct for type I error. This 
method is commonly used in proteomics because it is less stringent, while still maintaining 
adequate false discovery rates and sensitivity [183, 184]. Proteins that were significantly different 
between groups (control vs sham, control vs active TMS, and active TMS vs sham) were entered 
into the Ingenuity Pathway Analysis suite (QIAGEN, Inc.) to determine the protein interaction 
pathways and molecular function [183]. This allows for analysis of well-established signaling and 
metabolic pathways such as long-term potentiation or depression, as well as visualization of 
molecular contributions to these pathways. Ingenuity Pathway Analysis determines which network 
connections are unlikely to happen in a random model, with activation z-scores that use a 
statistically significant pattern match of regulation to predict the activation state of the regulator 
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[183]. The algorithms used in this analysis program were described in a study published in 
Bioinformatics [185].  
5.3 Results and Discussion 
Results indicated that 168 proteins exhibited differences in expression between the control 
and sham-tinnitus group, 89 proteins were significantly different between the TMS and sham 
group, and 389 proteins were different between the control and TMS group. Figure 5.1 shows a 
representative chromatogram from our study, illustrating the large coverage of peptide 
identification in AC tissue. This data represents the total ion current measured over the 3-hour 
eluting time. Prior to testing, we identified neurotransmitters known to play a significant role in 
neural plasticity or inhibitory networks that had also been identified in previous mass spectrometry 
studies from our equipment. Figure 5.2 shows the results from GAD67, GAD65, TrkB (the BDNF 
receptor), and GABA receptor-associated protein-like-2. A reduction in free GABA concentration 
has possible links to reductions in the levels of GAD protein across cortical layers [60, 177, 186]. 
However, GAD synthetic enzymes showed diverging effects following TMS treatment. GAD67 
was reduced for both the sham and active groups in comparison to the controls, while GAD65 
remained the same for the sham group and was significantly increased in the active TMS group. 
Differential effects on GAD67 and GAD65 have been previously reported in an vitro study that 
used paired-pulse stimulation of the hippocampus to evoke maximum amplitude population spikes 
in rats for 24 hours, which increased GAD67 concentrations in granule cells (also found in layer 
IV of the AC), but had no effect on GAD65 [178]. Vigabatrin, a drug which selectively inhibits 
GABA transaminase, was found to decrease GAD67 in almost all regions of the rat brain, while 
not affecting GAD65 levels anywhere except the cerebellum [187]. Aging is associated with 
reduced inhibition in cortical neurons, and has also been found to reduce protein levels of GAD67 
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by 40%–60% across layers of A1 [177]. TMS treatment was shown to increase neural measures 
of inhibition in the AC, and this may explain the increase in GAD65 levels. Low-frequency (1 Hz) 
TMS has also been shown to increase GAD65 in the visual, frontal, motor, somatosensory cortex 
in rats [188]. GAD65 is related to the rate of synaptic GABA release, and the authors suggested 
that this GAD65 increase could indicate activation of inhibitory interneurons [188]. These results 
also show that TMS restored levels of the BDNF TrkB receptor in the AC in comparison to the 
sham-treated group. These results suggest that TMS treatment may reverse the metabolic shifts 
associated with acoustic trauma and maladaptive disorders, since BDNF can affect GABAergic 
inhibition and alter plasticity in the central auditory system [66, 67].  
We also analyzed the metabolic and cell-signaling pathways that were altered due to 
changes in the expression of contributing molecules between the control group and sham/active 
groups. Figure 5.3 shows the 28 pathways significantly altered between the control group and 
either the active or the sham groups. Two pathways were significantly activated in the sham group 
in comparison to the control group – synaptic long-term potentiation and calcium signaling. In the 
active-treated tissue, these pathways were no longer altered when compared to the control group. 
Previous studies have shown that long-term potentiation is associated with tinnitus [147, 181], 
consistent with our results. TMS treatment has also been shown to affect synaptic plasticity in the 
cortical areas through both long-term potentiation and long-term depression, depending on the 
protocol used [76]. This may account for why the synaptic potentiation pathway was no longer 
different from the control group following active treatment. The calcium-signaling pathway was 
also modulated in AC tissue from the tinnitus group. Molecules involved in calcium signaling are 
predominately used in signal transduction in the auditory system [189]. A study in NMRI mice 
found that noise-trauma caused an enhancement in overall calcium dependent neuronal activity 
60 
throughout the central auditory system, seemingly reflecting neural hyperactivity, though this 
study was examining hearing loss and not tinnitus [182]. Long-lasting enhancement of sound 
evoked activity using manganese-enhanced magnetic resonance imaging signals suggest that there 
is noise-induced activity of calcium-dependent processes [182]. Overall, the analysis of protein 
expression revealed significant differences between the sham-treated tinnitus and control groups, 
which following active TMS treatment reverted to the normal profile.  
 
 
Figure 5.1 Representative total ion current chromatogram. The chromatogram displays the 
intensities of eluting peptides over a three-hour gradient, representing the summed intensity across 
the entire range of masses. Each peak represents a compound entering the detector, with larger 
concentrations creating higher amplitude peaks.  
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Figure 5.2 Differences in protein expression between groups. The top left panel shows the 
changes in relative protein expression for GAD67, where both the active and sham were lower 
than the control group, though only the active group was significantly different (t=2.7, p=0.034). 
The bottom left panel shows the expression for GAD65, demonstrating that levels for the active-
TMS group were significantly higher than the sham group (t=11.8, p=0.001). The top right panel 
shows the BDNF TrkB receptor levels, which indicated a clear trend to restoration of expression, 
though there was no overall significant effect. Lastly, the bottom right panel shows GABA 
receptor-associated protein-like-2, where there was a significant different between the active and 
sham groups (t=2.8, p=0.044). 
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Figure 5.3 Tinnitus and TMS-related differences in pathway activation. There were 28 
pathways that the Ingenuity Pathway Analysis indicated were significantly altered between the 
control group and either the active (left column) or sham (right column) groups. The pathways are 
listed on the left with significance denoted by the colored shading on the right. Orange indicates 
that the pathway was activated, and blue indicates that the pathway was inhibited, with darker 
colors demonstrating more extreme z-scores and the dot indicating no significant difference 
between the control group and the active/sham group. The two pathways which were activated in 
the sham group and restored to normal by active TMS were the synaptic long-term potentiation 
pathway and the calcium signaling pathway.  
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Figure 5.4 Molecules associated with synaptic long-term potentiation that were altered 
between the sham and control groups. Five of the six molecules related to the activation of 
synaptic long-term potentiation identified in the AC tissue were up- or down-regulated as expected 
(top panel). The bottom panel shows the pathway, with the red indicating nodes that were up-
regulated, for example AMPAR, and green showing nodes that were down-regulated. This 
pathway analysis illustrates the changes that occurred in the post-synaptic neuron. 
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Chapter 6: Summary of Results and Future Works 
 
This dissertation advances the collective knowledge of the underlying mechanisms of 
tinnitus and provides evidence on how TMS effectively treats this hearing disorder. TMS was used 
in only one prior animal study of tinnitus, where treatment successfully reduced behavioral 
evidence of tinnitus but no underlying neural markers of tinnitus were found within the auditory 
midbrain nuclei tested [81]. This dissertation significantly expands on that work, evaluating neural 
responses from the brainstem, midbrain, and AC in addition to using behavioral methodology to 
confirm the tinnitus percept. The AC was then removed, and levels of protein expression were 
quantified using mass spectrometry. These results demonstrate that TMS can reduce behavioral 
evidence of tinnitus in mice, and that this is likely due to shifting the broadened eFRAs towards 
normal values and reducing the hyperactive spontaneous and evoked activity in the AC. There 
were significant changes in presynaptic activity associated with inhibitory networks from the upper 
layers of the AC, indicating the importance of intracortical networks that play a crucial role in 
sound perception. TMS also reduced the significant activation of the synaptic long-term 
potentiation and calcium signaling pathways that was seen in the sham-treated tinnitus group‘s 
tissue in comparison to the control tissue, and modified expression of proteins tied to inhibitory 
networks. 
The second chapter evaluates neural mechanisms that underlie the behaviorally measured 
tinnitus percept, where results showed that measures of hyperactivity begin in the brainstem. Here, 
the ratio of activity in the CN to the auditory nerve was significantly increased in a drug-induced 
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tinnitus model, and this change correlated with deficits in the salience of a silent gap. These results 
were important for validating assessments for the identification of animals demonstrating evidence 
of experiencing the tinnitus percept for future testing of potential therapeutic treatments. This 
Chapter also identified another measure of tinnitus that may have potential for clinical 
applications, using brainstem evoked potentials to silent gaps in narrowband noise  
The third chapter demonstrates the efficacy of the custom rodent-sized TMS coil used 
throughout this dissertation, which is achieves more focal stimulation than the human-sized coils 
used in other rodent studies of TMS, and therefore is more realistic for comparison to human 
treatment. The custom coil was capable of increasing motor evoked potential amplitudes and was 
shown to induce an electric field in the brain above the threshold needed for neural activation. This 
work paves the way for testing TMS not only in rodent tinnitus models, but also for those used in 
studying Parkinson’s, Alzheimer’s, schizophrenia, and other neurological disorders.   
The fourth chapter details the behavioral and electrophysiological changes that occurred 
during TMS treatment. This study demonstrated that increases in Q-values and reductions in 
evoked and spontaneous firing rates induced by the active TMS treatment may be the underlying 
factors in the reduced behavioral evidence of tinnitus for this group. These measures are affected 
by alterations in cortical inhibition, and therefore our study provides further evidence that 
inhibitory networks play a key role in the treatment of tinnitus. This study also showed that the 
TMS treated group had similar LFP amplitudes to those seen in the control group, in comparison 
to large decreases observed in the sham-treated group. While it was unexpected to see LFP 
amplitudes decrease across all layers in the sham-treated tinnitus group, this is likely due to the 
LFP reflecting primary inhibitory neural activity, which has been demonstrated in a recent study 
in human and monkey models. Along these lines, dendritic inhibition has been found to enhance 
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LFP amplitudes while preventing the occurrence of action potentials in pyramidal cells, and TMS 
has been shown to activate dendritic inhibition, again indicating that increased inhibition may be 
the underlying mechanism for the relief from tinnitus seen in clinical trials. Results from the TMS 
treatment also demonstrated that presynaptic activity was significantly increased when compared 
to the sham treatment group in the upper layers of the cortex, which are responsible for intracortical 
processing and crucial to generation of sound perception. Figure 6.1 demonstrates a conceptual 
diagram of changes in behavioral and electrophysiological measures following noise-induced 
tinnitus, tying together the interaction to form the tinnitus perception. Figure 6.2 is a diagram of 
the improvements in the maladaptive plasticity related changes in AC function and shows the 
likely mechanisms of the underlying positive effects. This conceptual framework illustrates a 
model in which response tuning of the layer IV cells is determined by feedforward excitation from 
the thalamus and inhibition from the supragranular layer GABAergic interneurons [190], which is 
interrupted through the maladaptive plasticity induced changes in the balance of 
inhibition/excitation accompanying tinnitus. TMS has been shown to activate the upper layer 
inhibitory neurons which in turn suppresses activity in the layer IV pyramidal cells, likely 
underlying the reduction of the tinnitus percept. This suppression of maladaptive oscillatory neural 
activity is likely underlying the reduction of the tinnitus percept. 
The fifth chapter shows that TMS had a significant effect on many proteins in the AC, 
including receptors such as GAD67. A change in free GABA concentration has possible links to 
reductions in the levels of GAD67 across cortical layers [60, 177, 186]. TMS also appeared to 
restore levels of the BDNF receptor, TrkB, in the AC in comparison to the sham-treated group. 
This receptor has been shown to increase following TMS and plays a role in inhibition. The sham-
treated tinnitus group showed significant activation of the synaptic long-term potentiation and 
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calcium signaling pathways in comparison to the control group, both of which were restored to 
normal levels in the active TMS group. These results suggest that TMS treatment may alter 
maladaptive plasticity and presynaptic activity associated with tinnitus. 
Another significant aspect of this dissertation work was that it established an effective 
rodent model of TMS, which can be used for refining parameters to optimize TMS treatment in 
humans. Future studies could expand on this study by varying parameters such as the duration of 
treatment, using bilateral (either on rotating days or every day) TMS cortical treatment, and 
assessing the impact of varying the intensity of the magnetic field. The location of the TMS coil 
could also be changed to include the CN or midbrain. A long-term study that determines the 
average duration of improvements in behavioral and other measures of TMS-induced tinnitus 
treatment would be especially useful in helping to design clinical trials. Currently, human studies 
have shown suppression of the tinnitus percept in the majority of patients that were sustained over 
the 26-week follow-up period [110], but the average duration of tinnitus relief is unknown.  
Though tinnitus-related cortical changes demonstrated in other studies of tinnitus were 
improved by TMS treatment, there was no recovery of the reduced BF range measured in the AC. 
However, many studies call into question whether tonotopic reorganization of the AC is necessary 
for development of the tinnitus percept, and it has been shown that it is not present in tinnitus 
models without hearing loss. This study also leads to another major question as to how unilateral 
treatment, in this case TMS, can be effective when the tinnitus is perceived binaurally. Unilateral 
TMS has been used to effectively treat patients with bilateral tinnitus, though there is little analysis 
or discussion of how the hemisphere contralateral to treatment is affected. However, one study of 
low frequency TMS in healthy subjects found that there were significant changes across brain 
hemispheres due to long-range cortico-cortical connections, indicating that there are likely global 
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effects of repetitive TMS treatment. Future work should include a measure of activity in the 
contralateral AC, to provide much needed insight into how TMS affects long-range neural 
connections.  
Prospective future experimental changes include expanding the frequency range of the 
behavioral tests for tinnitus and adding a longitudinal measure of cortical activity such as the 
auditory steady-state response. More narrowband frequency gap carriers for behavior would allow 
for better identification of the tinnitus pitch, and the ability to examine correlations between these 
and neural responses. Altering these experimental parameters does come with potential downsides 
– one is that habituation of the acoustic startle response can occur when behavioral test times are 
increased. The second is the extended exposure to anesthetic while evoked potentials are collected, 
which can alter cortical activity and increases the risk for mortality in mice. Another addition to 
experimental procedures could be further CSD analysis through the collection of tone-evoked 
LFPs. One study showed that the CSD sink-source profile was significantly different when tones 
at the neuron’s BF were presented versus frequencies farther away from it [191]. The downsides 
to this are that a high number of repetitions are needed to increase the signal-to-noise of the LFP 
responses and adding multiple intensities and frequencies could significantly increase collection 
time. While there are many additions that may prove useful in further trials, this work provides a 
foundation for the study of TMS that may prove highly impactful for clinical treatment of tinnitus. 
 
69 
 
Figure 6.1 Potential mechanisms of tinnitus. This conceptual diagram highlights the observed 
changes in our noise-induced tinntius model, including LFP/CSD activity, molecular pathway 
activation, and changes in firing rates. It also demonstrates the likely mechanisms throughout the 
auditory pathway that may underly these tinnitus-related neural and behavioral changes.  
 
 
 
Figure 6.2 Potential mechanisms of TMS treatment of tinnitus. This diagram displays the 
observed changes induced with TMS treatment in our noise-induced tinntius model, including 
improvements in behavioral evidence of tinnitus, LFP/CSD activity, and firing rates. It also 
highlights the likely neural and molecular mechanisms in the AC that may underly the positive 
effects of treatment.  
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Appendix A: Abbreviations 
 
Auditory Brainstem Response ABR 
Auditory Cortex  AC 
Brain Derived Neurotrophic Factor BDNF 
Best Frequency BF 
Cochlear Nucleus CN 
Current Source Density CSD 
Excitatory Frequency Response Area eFRA 
Gamma-Aminobutyric Acid GABA 
Gap Pre-pulse Inhibition of the Acoustic Startle GPIAS 
Glutamate Decarboxylase 1 GAD67 
Glutamate Decarboxylase 2 GAD65 
Inferior Colliculus IC 
Local Field Potential LFP 
Minimum Threshold MT 
Multi-Unit MU 
Noise Pre-pulse Inhibition of the Acoustic Startle NPIAS 
Peak 1/2/4 P1/P2/P4 
Transcranial Magnetic Stimulation TMS 
BDNF/NT-3 growth factors receptor TrkB  
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Appendix C: Alterations in Peripheral and Central Components of the Auditory Brainstem 
Response: A Neural Assay of Tinnitus 
 
Appendix C contains the manuscript titled, “Alterations in Peripheral and Central 
Components of the Auditory Brainstem Response: A Neural Assay of Tinnitus”, published by 
PLOS ONE. 
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Appendix D contains the manuscript titled, “Construction and Evaluation of Rodent-
Specific rTMS Coils”, published by Frontiers in Neural Circuits. 
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